Tag:
Symphogen
Latest Headlines
Latest Headlines
Symphogen lines up record $131M venture round
Symphogen CEO Kirsten Drejer will have something big to boast about when she shows up at the JP Morgan confab next week. The Danish biotech reports this morning that it has nailed a whopping $131
Rib-X gets Phase II results, $25M in financing
It was a good news day at New Haven, CT-based Rib-X Pharmaceuticals. First, the company announced positive Phase II results from a Phase II clinical trial of delafloxacin (RX-3341) for complicated
Symphogen inks $330M collaboration pact with Genentech
Denmark's Symphogen has inked a $330 million collaboration deal with Genentech to discover new antibodies for three infectious disease
